Provided by Tiger Trade Technology Pte. Ltd.

Insmed

121.82
+3.282.77%
Pre-market: 121.820.00000.00%08:16 EDT
Volume:2.39M
Turnover:289.11M
Market Cap:26.60B
PE:-29.80
High:122.71
Open:118.68
Low:117.51
Close:118.54
52wk High:212.75
52wk Low:90.39
Shares:218.38M
Float Shares:216.82M
Volume Ratio:1.37
T/O Rate:1.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0882
EPS(LYR):-6.4200
ROE:-87.22%
ROA:-22.17%
PB:35.12
PE(LYR):-18.98

Loading ...

Insmed Surges After Q2 Revenue Beat

Reuters
·
Aug 06

Insmed Q2 FY26 Net Loss Narrows to $13.2 Million; Revenue Rises 296% to $425.5 Million

Reuters
·
Aug 06

Movement Alert|Insmed Pre-Market Rise 17.15%, Q2 Earnings Massively Beat Expectations with Near-Breakeven EPS

Market Focus
·
Aug 06

Earnings Flash (INSM) Insmed Posts Q2 Loss $0.06 a Share, vs. FactSet Est of $0.69 Loss

MT Newswires Live
·
Aug 06

Insmed Q2 EPS $(0.06) Beats $(0.73) Estimate, Sales $425.486M Beat $392.836M Estimate

Benzinga Earnings
·
Aug 06

Stock Track | Insmed Soars 14.21% in Pre-market on Q2 Revenue Beat

Stock Track
·
Aug 06

Insmed Q2 EPS USD -0.06

Reuters
·
Aug 06

Insmed : Raises FY 2026 Brinsupri Revenue Guidance to $1.25 Bln -$1.40 Bln

THOMSON REUTERS
·
Aug 06

Earning Preview: Insmed Q2 revenue expected to increase by 278%, institutions lean positive on profitability ramp

Earnings Agent
·
Jul 31

Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Insmed (INSM) and Edwards Lifesciences (EW)

TIPRANKS
·
Jul 28

Insmed Chair and CEO William Lewis Disposes of 10,700 Common Shares Worth $1.14 Million

Reuters
·
Jul 25

Insmed to Release Q2 2026 Results, Host Investor Conference Call

Reuters
·
Jul 23

Insmed (INSM) Stock Could Be Pricey As Its 4.4x Run Continues

Simply Wall St.
·
Jul 22

Guggenheim Reaffirms Their Buy Rating on Insmed (INSM)

TIPRANKS
·
Jul 22

Ritu Baral Reaffirms Buy on Insmed, Raising Price Target from $200 to $243 Ahead of Q2 Preview

TIPRANKS
·
Jul 22

Insmed initiated with an Outperform at BMO Capital

TIPRANKS
·
Jul 21

Is Insmed (INSM) Undervalued After Positive TPIP Data Backed A Phase 3 Push?

Simply Wall St.
·
Jul 20

Insmed (INSM) Reports 12 Month TPIP Data That Sets Up Phase 3

Simply Wall St.
·
Jul 19

Analysts’ Top Healthcare Picks: Insmed (INSM), Illumina (ILMN)

TIPRANKS
·
Jul 17

Analysts Offer Insights on Healthcare Companies: Insmed (INSM), AbCellera Biologics (ABCL) and DBV Technologies SA – American (DBVT)

TIPRANKS
·
Jul 17